There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot because of a lack of ...
If approved, the Pfizer-Valneva vaccine could become highly sought-after as Lyme disease surges in the Hudson Valley.
The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...
Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see ...
The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.
Scientists found that the experimental vaccine was more than 70% effective at preventing Lyme disease in a trial of nearly 10 ...
Shares of Valneva VALN tanked 37% on Monday after the company reported top-line results from the phase III VALOR study, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results